PH-762

N/A

Report date: 2025/05/08 16:35:31
NME

Base Information

Drug NamePH-762
Drug Alias NamePH-762PH762-ACTRXI 762-ACTmPH-762PH762-TME
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionProgrammed cell death protein 1 blockersRNA interference
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsSkin MelanomaGenital Neoplasms, FemaleUrogenital Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPhio Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesPhio Pharmaceuticals IncAgonOx IncPhio Pharmaceuticals Corp
Inactive CompaniesN/A
Active IndicationsSkin MelanomaGenital Neoplasms, FemaleUrogenital Neoplasms +[9] 
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A